China Life Insurance Co Ltd
SSE:601628
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
China Life Insurance Co Ltd
Total Equity
China Life Insurance Co Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
China Life Insurance Co Ltd
SSE:601628
|
Total Equity
¥595.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
Ping An Insurance Group Co of China Ltd
SSE:601318
|
Total Equity
¥1T
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
12%
|
|
|
New China Life Insurance Company Ltd
SSE:601336
|
Total Equity
¥111.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
|
H
|
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
|
Total Equity
¥21.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
30%
|
|
|
S
|
Sunshine Insurance Group Co Ltd
HKEX:6963
|
Total Equity
¥62.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
China Life Insurance Co Ltd
Glance View
China Life Insurance Co Ltd stands as a colossal figure within the realm of financial services in China, rooted in a rich history that traces back to its inception in 1949. Positioned at the strategic intersection of finance and protection, the company serves as a beacon of security for millions across the nation. This enterprise, listed on both the Hong Kong and New York Stock Exchanges, has expertly woven itself into the fabric of Chinese society by providing a comprehensive suite of services ranging from individual life insurance, group life insurance, accident insurance, and health insurance. Its operational model hinges on its expansive distribution network, comprising an army of adept agents, alongside a seamlessly integrated bancassurance structure, which collaborates with banks to maximize reach and accessibility. Through this extensive network, China Life not only fortifies its market dominance but also cultivates trust and loyalty among its vast clientele. Revenue streams for China Life Insurance primarily flow through its underwriting of life insurance policies, which serve as the bedrock of its profitability. By pooling client premiums, the company invests these funds into diverse portfolios, encompassing stocks, bonds, and real estate, thus ensuring a steady income stream derived from both returns on investments and new policy sales. The delicate balance between managing risks and optimizing investments underscores its business strategy, leveraging China's economic expansion and an increasing middle class with a heightened awareness of financial security needs. This dual engine of premium collection and investment income propels China Life forward, reinforcing its stature as not only a cornerstone in China's insurance sector but an embodiment of financial stability and growth in the ever-evolving economic landscape.
See Also
What is China Life Insurance Co Ltd's Total Equity?
Total Equity
595.2B
CNY
Based on the financial report for Dec 31, 2025, China Life Insurance Co Ltd's Total Equity amounts to 595.2B CNY.
What is China Life Insurance Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
6%
Over the last year, the Total Equity growth was 17%. The average annual Total Equity growth rates for China Life Insurance Co Ltd have been 11% over the past three years , 6% over the past five years , and 6% over the past ten years .